ARCTOS medical

Bern, Switzerland Founded: 2018 • Age: 8 yrs Acquired By Novartis
Optogenetic therapies for retinal degenerative diseases are developed.

About ARCTOS medical

ARCTOS medical is a Healthcare company based in Bern (Switzerland) founded in 2018, and was acquired by Novartis in September 2021. Optogenetic therapies for retinal degenerative diseases are developed. Its focus areas include Life Sciences, Ophthalmology, Drugs and Retinal Disorders.

Company details

ARCTOS medical was founded in 2018 in Bern, Switzerland, within the biotechnology sector. Optogenetic therapies targeting retinal degenerative diseases are developed using adeno-associated virus gene therapy. Replacement photoreceptors incorporating optogenes are designed to activate specific cells in the retina. Applications focus on addressing blindness linked to conditions such as retinitis pigmentosa and age-related macular degeneration. Operations center on preclinical and clinical advancements in gene-based vision restoration.

Operational Areas
Key Metrics

Investors in ARCTOS medical

ARCTOS medical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Novartis.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
R&D focused on manufacturing of drugs for multiple therapeutic areas
1996novartis.comBasel, Switzerland
Premium access

Investor details for ARCTOS medical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of ARCTOS medical

2 dated milestones of ARCTOS medical across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded ARCTOS medical is founded.
  2. Exit Acquired by Novartis.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about ARCTOS medical

ARCTOS medical was founded in 2018.

ARCTOS medical is headquartered in Bern, Switzerland. It is registered at Bern, Bern, Switzerland.

ARCTOS medical was founded in 2018 in Bern, Switzerland, within the biotechnology sector. Optogenetic therapies targeting retinal degenerative diseases are developed using adeno-associated virus gene therapy. Replacement photoreceptors incorporating optogenes are designed to activate specific cells in the retina. Applications focus on addressing blindness linked to conditions such as retinitis pigmentosa and age-related macular degeneration. Operations center on preclinical and clinical advancements in gene-based vision restoration.

ARCTOS medical has 1 investor. Key investors include Novartis.

Yes. ARCTOS medical was acquired by Novartis in September 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available